Bausch Health Companies — Cantor Global Healthcare Conference 2019

4 slides from Bausch Health Companies's conference presentation, Oct 2, 2019

Slide 1: DUOBRII Launch Update
DUOBRII® Launch Update Cantor Global Healthcare Conference October 2, 2019
Slide 2: DUOBRII Launch Seeing Rapid Uptake
DUOBRII® Launch Seeing Rapid Uptake DUOBRII® Weekly TRx Trend1 2,700 2,427 • Strong adoption by doctors, 2,400 patients and managed care driving weekly TRx growth 2,100 1,800 1,500 1,200 900 commercial access at 43% 600 3 months post launch 300 0 Week Week Week Week Week Week Week Week Week Week Wee
Slide 3: >4,000 Unique Prescribers to Date Since Launch
>4,000 Unique Prescribers to Date Since Launch1 4,500 4,293 4,000 Number of Unique Prescribers to Date Since Launch 3,500 3,000 2,500 2,000 1,500 1,000 500 0 6/28/19 7/05/19 7/12/19 7/19/19 7/26/19 8/2/19 8/9/19 8/16/19 8/23/19 8/30/19 9/6/19 9/13/19 2 1. IQVIA Sub-National weekly data 9/13/2019.
Slide 4: Strong Launch Comparisons in Dermatology
Strong Launch Comparisons in Dermatology1 TM Eucrisa® (dermatologist specialty only) Dupixent® Altreno® Duobrii® Bryhali Enstilar® 2 5,000 4,500 4,000 3,500 3,000 2,427 TRx 2,500 2,000 1,500 1,000 500 0 3 1. IQVIA RAPID weekly NPA; trademarks are property of respective owners. 2. Enstilar weekly tre